Nuveen’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.4M | Sell |
139,139
-51,862
| -27% | -$3.33M | ﹤0.01% | 1661 |
|
|
2026
Q1 | $10.8M | Sell |
191,001
-43,574
| -19% | -$2.84M | ﹤0.01% | 1506 |
|
|
2025
Q4 | $18.8M | Buy |
234,575
+101,282
| +76% | +$6.8M | ﹤0.01% | 1179 |
|
|
2025
Q3 | $6.5M | Sell |
133,293
-5,294
| -4% | -$328K | ﹤0.01% | 1781 |
|
|
2025
Q2 | $10.3M | Sell |
138,587
-24,119
| -15% | -$1.6M | ﹤0.01% | 1488 |
|
|
2025
Q1 | $10.3M | Buy |
162,706
+1,254
| +0.8% | +$85.3K | ﹤0.01% | 1532 |
|
|
2024
Q4 | $12.6M | Sell |
161,452
-19,887
| -11% | -$1.6M | ﹤0.01% | 1471 |
|
|
2024
Q3 | $14.6M | Sell |
181,339
-460
| -0.3% | -$37.2K | ﹤0.01% | 1388 |
|
|
2024
Q2 | $15M | Buy |
181,799
+1,932
| +1% | +$170K | ﹤0.01% | 1322 |
|
|
2024
Q1 | $15.4M | Buy |
179,867
+61
| +0% | +$4.79K | ﹤0.01% | 1335 |
|
|
2023
Q4 | $15.4M | Buy |
179,806
+2,033
| +1% | +$176K | ﹤0.01% | 1330 |
|
|
2023
Q3 | $15.9M | Sell |
177,773
-184
| -0.1% | -$16.4K | 0.01% | 1178 |
|
|
2023
Q2 | $15.2M | Buy |
177,957
+6,038
| +4% | +$510K | 0.01% | 1256 |
|
|
2023
Q1 | $14.2M | Sell |
171,919
-23,092
| -12% | -$1.87M | 0.01% | 1260 |
|
|
2022
Q4 | $15.3M | Buy |
195,011
+3,655
| +2% | +$294K | 0.01% | 1215 |
|
|
2022
Q3 | $14.2M | Buy |
191,356
+6,350
| +3% | +$456K | 0.01% | 1248 |
|
|
2022
Q2 | $12.1M | Sell |
185,006
-5,525
| -3% | -$327K | ﹤0.01% | 1391 |
|
|
2022
Q1 | $10.6M | Buy |
190,531
+153
| +0.1% | +$8.32K | ﹤0.01% | 1601 |
|
|
2021
Q4 | $10.1M | Sell |
190,378
-25,956
| -12% | -$1.58M | ﹤0.01% | 1687 |
|
|
2021
Q3 | $15.3M | Sell |
216,334
-37,440
| -15% | -$2.36M | ﹤0.01% | 1466 |
|
|
2021
Q2 | $16.9M | Buy |
253,774
+66,413
| +35% | +$4.7M | 0.01% | 1504 |
|
|
2021
Q1 | $20.8M | Sell |
187,361
-17,435
| -9% | -$2.16M | 0.01% | 1288 |
|
|
2020
Q4 | $24.3M | Buy |
204,796
+59,959
| +41% | +$6.45M | 0.01% | 1127 |
|
|
2020
Q3 | $12.6M | Sell |
144,837
-14,629
| -9% | -$1.28M | ﹤0.01% | 1366 |
|
|
2020
Q2 | $14.3M | Sell |
159,466
-326,919
| -67% | -$33M | 0.01% | 1249 |
|
|
2020
Q1 | $48.5M | Buy |
486,385
+164,741
| +51% | +$17.9M | 0.02% | 503 |
|
|
2019
Q4 | $37M | Sell |
321,644
-44,177
| -12% | -$5.35M | 0.01% | 833 |
|
|
2019
Q3 | $46.1M | Sell |
365,821
-54,758
| -13% | -$6.95M | 0.02% | 693 |
|
|
2019
Q2 | $50.6M | Buy |
+420,579
| New | +$41.4M | 0.02% | 679 |
|
|
2014
Q1 | – | Sell |
-33,809
| Closed | -$1.42M | – | 1597 |
|
|
2013
Q4 | $1.42M | Sell |
33,809
-33,049
| -49% | -$1.36M | 0.01% | 928 |
|
|
2013
Q3 | $2.67M | Buy |
66,858
+7,495
| +13% | +$314K | 0.02% | 691 |
|
|
2013
Q2 | $2.46M | Buy |
+59,363
| New | +$2.4M | 0.02% | 690 |
|
Other funds holding HAE
AI
Nuveen's HAE Position: Q2 2026 in Review
Nuveen reduced its Haemonetics (HAE) stake by 27% in Q2 2026, selling an estimated $3.33M and leaving 139,139 shares worth $10.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1661.
Nuveen first reported a position in HAE in Q2 2013 and has held it in 32 quarters since. The position peaked at $50.6M in Q2 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Nuveen held 139,139 shares of Haemonetics worth $10.4M as of Q2 2026.
- Nuveen sold 51,862 Haemonetics shares in Q2 2026, an estimated $3.33M.
- Haemonetics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1661 holding.
- Nuveen first reported a position in Haemonetics in Q2 2013 and has held it in 32 quarters since.
- Nuveen's Haemonetics position peaked at $50.6M in Q2 2019.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.